Neuroone Medical Technologies (NMTC) Change in Receivables (2020 - 2026)
Neuroone Medical Technologies' (NMTC) quarterly Change in Receivables came in at -$764484.0 in Q1 2026, up 62.71% YoY from -$469843.0 in Q1 2025, and down 154.72% on a QoQ basis from $1.4 million in Q4 2025.
Neuroone Medical Technologies (NMTC) Change in Receivables (2020 - 2026) Analysis & Trends
Neuroone Medical Technologies (NMTC) has 7 years of Change in Receivables data on file, last reported at -$764484.0 in Q1 2026.
- Quarterly Change in Receivables rose 62.71% year-over-year to -$764484.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.6 million (up 766.47% YoY) and the FY2025 annual result came in at $1.1 million, up 516.05% from the prior year.
- Change in Receivables eased to -$764484.0 in Q1 2026, from $1.4 million in the prior quarter.
- In the past five years, Change in Receivables ranged from a high of $2.2 million in Q4 2024 to a low of -$2.1 million in Q1 2025.
- A 5-year average of $117047.2 and a median of $12098.0 in 2022 frame the typical range for Change in Receivables.
- Annual changes were most pronounced in 2023 — Change in Receivables soared 892.25% — and 2025, when it plunged 16849.45%.
- Tracing NMTC's Change in Receivables over 5 years: stood at $62082.0 in 2022, then surged by 775.29% to $543399.0 in 2023, then jumped by 303.44% to $2.2 million in 2024, then plunged by 36.27% to $1.4 million in 2025, then tumbled by 154.72% to -$764484.0 in 2026.
- The last three Change in Receivables figures came in at -$764484.0 (Q1 2026), $1.4 million (Q4 2025), and $1.3 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 386.00 Mn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 177.00 Mn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 287.00 Mn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 46.00 Mn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 10.20 Mn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 172.10 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 79.00 Mn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | - |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | -90.00 Mn |
| 10 | Neuroone Medical Technologies | 19.64 Mn | 17.59 Mn | 1.18 Mn | -798,418.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -798,418.00 |
| Jun 30, 2026 | -798,418.00 |
| Mar 31, 2026 | -764,484.00 |
| Mar 31, 2026 | -764,484.00 |
| Dec 31, 2025 | 1.40 Mn |
| Dec 31, 2025 | 1.40 Mn |
| Sep 30, 2025 | 1.26 Mn |
| Sep 30, 2025 | 1.26 Mn |
| Jun 30, 2025 | -318,780.00 |
| Jun 30, 2025 | -318,780.00 |
| Mar 31, 2025 | -2.05 Mn |
| Mar 31, 2025 | -2.05 Mn |
| Dec 31, 2024 | 2.19 Mn |
| Dec 31, 2024 | 2.19 Mn |
| Sep 30, 2024 | -233,915.00 |
| Sep 30, 2024 | -233,915.00 |
| Jun 30, 2024 | -145,088.00 |
| Jun 30, 2024 | -145,088.00 |
| Mar 31, 2024 | 12,240.00 |
| Mar 31, 2024 | 12,240.00 |